万赛维国内入医保没？

(valcyte) is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS), and valcyte (valcyte) is indicated for the prevention of CMV infection in high-risk solid organ transplant patients. Valcyte is the L-valyl ester (prodrug) of ganciclovir. After oral administration, it is rapidly converted into ganciclovir by esterases in the small intestine and liver.

Cytomegalovirus infection is a common complication after organ transplantation, with an incidence rate as high as 50%. The pain caused by organ rejection, cardiovascular disease, post-transplantation diabetes and related treatments has seriously affected the quality of life of patients. Valcyte is an oral anti-cytomegalovirus infection drug that combines the advantages of oral administration and intravenous injection. Just taking 2 tablets of valcyte per day can effectively prevent and treat cytomegalovirus infection, avoid the direct and indirect harm caused by cytomegalovirus infection, and significantly improve the patient's quality of life and long-term survival rate.

Vancevir is an oral medication and should be taken with food. The recommended dose for induction treatment of CMV retinitis in adults is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis.

In August 2006, Valcyte was launched in China, with a specification of 450mg*60 tablets/box and a price of $16,500/box. Although Valcyte has been on the market in my country for many years, Valcyte has not yet been included in medical insurance, which is undoubtedly a huge financial pressure for patients. In fact, patients may wish to choose Vancevir tablets launched in India, which are cost-effective and relatively cheap compared to domestic prices. 450mg*60 tablets cost about RMB 5,500 in Indian pharmacies.